Strensiq 40 mg

STRENSIQ 40 MG is a subcutaneous solution containing asfotase alfa, used for managing certain metabolic conditions. This medication is designed to support enzyme replacement therapy.

STRENSIQ 40 MG is primarily used for the treatment of hypophosphatasia, a rare metabolic disorder. Asfotase alfa, the active ingredient, helps to replace the deficient enzyme in the body. This medication is administered subcutaneously to support bone health and overall metabolic function.

Common effects of STRENSIQ 40 MG may include reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience fatigue or mild gastrointestinal discomfort. These effects are generally mild and temporary.

STRENSIQ 40 MG should be handled with care, ensuring proper storage and administration techniques. It is important to follow the guidance of a healthcare professional regarding the use of this medication. Always check for any signs of allergic reactions or unusual side effects.

STRENSIQ 40 MG may interact with certain medications or substances. It is advisable to inform your healthcare provider about all other medications you are taking, including over-the-counter drugs and supplements. Avoid mixing with other injectable medications without professional advice.